Zum Hauptinhalt springen

Naltrexon

05. Juli 2025 | Naltrexon

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study.

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study. Mordal J, Juya F, Holtan L, Vederhus JK, Opheim A, Brenna IH, Enger AE, Weimand B, Solli KK, Tanum L.&n…

05. Juli 2025 | Naltrexon

Comparison of Naltrexone Implant and Oral Buprenorphine Naloxone in The Treatment of Opioid Use Disorder: A Retrospective Cohort Study.

Comparison of Naltrexone Implant and Oral Buprenorphine Naloxone in The Treatment of Opioid Use Disorder: A Retrospective Cohort Study. Peker O, Peker İ, Çayköylü A. Noro Psikiyatr Ars. 2024 Aug 9;62(2):125-130. doi: 10.29399/npa.28738…

05. Juli 2025 | Naltrexon

Explaining increased efficacy of naltrexone in the treatment of alcohol dependent patients with a family history of alcohol use disorder: A systematic review on the role of reward sensitivity and sweet liking.

Explaining increased efficacy of naltrexone in the treatment of alcohol dependent patients with a family history of alcohol use disorder: A systematic review on the role of reward sensitivity and sweet liking. van Amsterdam J, van den Brink W…

07. Juni 2025 | Naltrexon

Sustained-release naltrexone for opioid dependence.

Sustained-release naltrexone for opioid dependence. Kornør H, Lobmaier PPK, Kunøe N. Cochrane Database Syst Rev. 2025 May 9;5(5):CD006140. doi: 10.1002/14651858.CD006140.pub3. PMID: 40342086; PMCID: PMC12063202. Abstract https://www…

08. Mai 2025 | Naltrexon

Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review.

Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review. Leiber KK, Parker RW. Cureus. 2025 Mar 24;17(3):e81086. doi: 10.7759/cureus.81086. PMID: 40271304; PMCID: PMC12017383. https://pmc.ncbi.nlm.nih.gov/articles/PMC12…

22. April 2025 | Naltrexon

Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial.

Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. Magane KM, Dukes KA, Fielman S, et al. JAMA Intern Med. Published online April 21, 202…

11. März 2025 | Naltrexon

Mining and disproportionality analysis of adverse events signals for naltrexone based on real-world data from the FAERS database.

Mining and disproportionality analysis of adverse events signals for naltrexone based on real-world data from the FAERS database. Zeng Y, Chen Z, Luo Y, Luo J, Shi L, Zhou X. Expert Opin Drug Saf. 2025 Feb 2:1-8. doi: 10.1080/14740338…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten